Key result
Dr. Richard H. Grimm, Jr., a leader in landmark clinical trials for hypertension management, died on September 8, 2022, at the age of 76.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
An obituary honoring the life and contributions of Dr. Richard H. Grimm, Jr. to the field of hypertension research.
Jr, whose leadership on several landmark clinical trials over the last 5 decades helped shape our contemporary management of hypertension, died peacefully on September 8, 2022 at the age of 76 years. He will be missed greatly by family, friends, and his colleagues, whom he thought of and treated like family. Dr Grimm was an innovative and independent thinker, never afraid to challenge mainstream opinions and articulate thoughtful, introspective viewpoints.
No takes yet. Share an insight, caveat, or question.
Ernst et al. (2023) reported an editorial. Dr. Richard H. Grimm, Jr., a leader in landmark clinical trials for hypertension management, died on September 8, 2022, at the age of 76.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: